Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases

Conclusions: We identified risk factors for extrahepatic progression after TACE in HCC patients. Early combination treatment was strongly recommended in patients that met these risk factors.

Source: Journal of Cancer - December 14, 2019 Category: Cancer & Oncology Authors: Shaohua Li, Qiaoxuan Wang, Jie Mei, Jianwei Wang, Xiao-Ping Zhong, Yihong Ling, Zhixing Guo, Liang-He Lu, Wei Wei, Rongping Guo Tags: Research Paper Source Type: research